The tumor masses were significantly reduced in the GSTO1‐KO group subjected to cisplatin treatment, whereas cisplatin had no obvious effect on the GSTO1‐OE group compared to the control (Fig. 7E,F). This evidence concerns the gene GSTO1 and neoplasm.